We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Guidance
Our Guidance explains the laws and regulations governing the development, manufacturing, marketing, and supply of therapeutic goods in Australia.
We recently introduced new features to improve your experience using Guidance on our website.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (32)
- Breast implant hub (1)
- Clinical trials (5)
- Committees and advisory bodies (2)
- Compliance and enforcement (30)
- Cosmetics (4)
- COVID-19 (11)
- Fees and payments (3)
- Import and export (9)
- Labelling and packaging (26)
- Legislation (9)
- Manufacturing (41)
- Medicinal cannabis hub (4)
- Metal-on-metal hip replacement implants hub (1)
- Safety monitoring and information (46)
- Scheduling (national classification system) (6)
- Shortages and supply disruptions (3)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Vaping hub (5)
- Weight loss products (1)
Search
292 result(s) found, displaying 251 to 275
-
GuidanceGuidance about when information released to the public about therapeutic goods is considered advertising.
-
GuidanceGuidance on the mandatory reporting scheme for medicine shortages and permanent discontinuations, and our approach to compliance.
-
GuidanceGuidance on what information to include in an application to vary the Therapeutic Goods (Permissible Ingredients) Determination.
-
GuidanceThis guidance is for sponsors intending to use the priority review pathway for biologicals.
-
GuidanceGuidance to help sponsors understand the process of submitting a priority inclusion application.
-
GuidanceGuidance explaining sponsor requirements for IVD conformity assessment through manufacturer agreements and regulatory compliance.
-
GuidanceGuidance on the stages of preparing and submitting an application for inclusion of a Class 2, 3 or 4 biological in the ARTG.
-
GuidanceAn outline of the regulatory process and a summary of the requirements to successfully submit a biologicals application.
-
GuidanceGuidance for holding acceptable evidence to support indications and claims made about your listed medicine.
-
GuidanceGuidance on submitting an effective prescription medicines application.
-
GuidanceThis guidance explains part 6 of the Code, which outlines requirements for using endorsements and testimonials in advertisements about therapeutic goods.
-
GuidanceGuidance on the process and regulatory requirements to register prescription medicines.
-
GuidanceGuidance about evidence required to substantiate the quality of the product, for over-the-counter (OTC) medicine registration applications.
-
GuidanceGeneral Guidance on the regulation of listed medicines and registered complementary medicines (RCM) in Australia.
-
GuidanceGuidance on submitting an effective application to register an over-the-counter (OTC) medicine.
-
GuidanceGuidance on information required for an effective application to register a complementary medicine and proceed to evaluation.
-
GuidanceThis guidance is for sponsors and manufacturers supplying medicines in Australia that are serialised or have data matrix codes.
-
GuidanceGuidance on clinical performance requirements and risk mitigation for in vitro diagnostic medical devices intended to be used as self-tests for seasonal influenza.
-
GuidanceTips for sponsors, distributors and retailers on creating prescription medicine labels that are compliant with Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91).
-
GuidanceGuidance to assist manufacturers of medical devices and their component parts with meeting their regulatory obligations.
-
GuidanceGuidance on obligations during provisional registration period, process for applying for extension of provisional registration and transition to full registration.
-
GuidanceThis guidance explains the administrative and prescribing (dossier) information you need to support the registration or variation of a prescription medicine.
-
GuidanceGuidance to help sponsors and manufacturers of therapeutic goods to understand and use the Poisons Standard to determine if any restrictions apply to their product.
-
GuidanceGuidance on how to access and use the Permissible Ingredients Determination for the purposes of submitting applications for substances in listed and assessed listed medicines.
-
GuidanceGuidance about the administrative information to support assessed listed medicine applications.